The strongly statistically significant higher SGPT levels in non-oncological patients (p<0.008) may imply a hepatotoxic effect of certain therapeutic agents or even an autoimmune hepatitis post-vaccination and warrants a more detailed analysis. This evidence concerns the gene GPT and autoimmune hepatitis.